Canada markets close in 1 hour 49 minutes

Aequus Pharmaceuticals Inc. (AQS.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.03000.0000 (0.00%)
As of 10:00AM EST. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) 3.32M
Enterprise Value 4.12M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.52
Price/Book (mrq)24.39
Enterprise Value/Revenue 1.86
Enterprise Value/EBITDA -2.19

Trading Information

Stock Price History

Beta (5Y Monthly) 0.56
52-Week Change 3-72.73%
S&P500 52-Week Change 3-13.20%
52 Week High 30.1200
52 Week Low 30.0200
50-Day Moving Average 30.0419
200-Day Moving Average 30.0634

Share Statistics

Avg Vol (3 month) 357.21k
Avg Vol (10 day) 371.08k
Shares Outstanding 5132.63M
Implied Shares Outstanding 6N/A
Float 8112.57M
% Held by Insiders 114.66%
% Held by Institutions 10.00%
Shares Short (Nov 14, 2022) 475.4k
Short Ratio (Nov 14, 2022) 42.65
Short % of Float (Nov 14, 2022) 4N/A
Short % of Shares Outstanding (Nov 14, 2022) 40.06%
Shares Short (prior month Oct 13, 2022) 435.62k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin -108.01%
Operating Margin (ttm)-100.89%

Management Effectiveness

Return on Assets (ttm)-37.72%
Return on Equity (ttm)-187.14%

Income Statement

Revenue (ttm)2.22M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)-46.80%
Gross Profit (ttm)2.69M
Net Income Avi to Common (ttm)-2.4M
Diluted EPS (ttm)-0.0130
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.39M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)188.77k
Total Debt/Equity (mrq)138.88
Current Ratio (mrq)0.78
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-1.62M
Levered Free Cash Flow (ttm)1.09M